Abstract: Ultraviolet (UV) light is an electromagnetic radiation below the visible wavelengths. Their use in cercariae attenuation needs to be examined. In the present work, Schistosoma mansoni cercariae was exposed to UV radiation. Few studies showed previously an inflicted damage seen on the adult schistosome worms developed from irradiated cercariae. The aim of the study was to find out whether this damage was attributed to direct effect of UV-irradiation on cercariae or due to the host's immunogenicity induced by UV- irradiated cercariae. Single as well as multiple exposures of cercariae to UV Light were examined. They were exposed to UV light, for 1, 2 and 3 hrs and then, were subjected to different treatments: the first one was for the assessment of cercarial viability after one hour of the 3 different treatments. The second one was for rabbit infection and the third one was for cercarial antigen preparation. The cercarial antigens (Ag) were recognized by protective antibodies (IgG1 fractions) which then, were separated and purified from vaccinated rabbit's serum. This cercarial Ag was identified as UVISmC1 gene encoding a protein showing 100% identity at the amino acid level with previously identified S. mansoni clones; theses clones are encoding 51.7 kDa antigens elicited as a result of direct effect of UV radiation on cercariae as well as host's immunogenicity induced by UV irradiated cercariae. This was verified by the recognition of this Ag prepared from E coli clones isolated from cDNA expression library. In conclusion, the data showed a remarkable potency of the UV-radiation-attenuated cercaria in eliciting differential high effectiveness in Ab response under laboratory conditions at 1, 2 and 3 hrs of UV light output at 254 nm. An understanding of the protective immune response elicited by RA cercaria may help in designing a candidate vaccine which is still needed.
Keywords: UV light, Schistosoma mansoni, radiation-attenuated cercariae, purification of IgG and vaccine.
[1]. Ahmed HM, Romeih MH, Sherif SA, Fahim FA, and Saber MA. Protection against Schistosoma mansoni infection with recombinant schistosomula 21.7 kDa protein. Arab Journal of Biotechnology, 2001, 24; 229-249.
[2]. Cantrell DA and Smith KA. The interleukin-2 system. A new cell growth model. Science 1984, 224:1312-15.
[3]. Cook PC, Aynsley SA, Turner JD, Jenkins GR, Van Rooijen N, Leeto M, Brombacher F. and Mountford AP.. Multiple helminth infection of the skin causes lymphocyte hypo-responsiveness mediated by Th2 conditioning of dermal myeloid cells. PLoS Patholog, Epub 2011, Mar 17; 7(3):e1001323.
[4]. Coulson PS .The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine? Adv Parasitol, 1997, 39: 271-336.
[5]. Dania R and Donald A. Candidate Vaccine Antigens Identified by Antibodies from Mice Vaccinated with 15- or 50-Kilorad-Irradiated Cercariae of Schistosoma mansoni Infection and Immunity, Jan. 1993, p. 146-154.
[6]. Dean DA: Schistosoma mansoni and related genera acquired resistance in mice. Exp parasitol, 1983, 55:1-104
[7]. Eberl, M., J., Langermans, P. A., Frost, R. A., Vervenne, G. J., van Dam, A. M., Deelder, A. W., Thomas, P. S. and Coulson, R. A. Cellular and humoral immune responses and protection against schistosomes induced by a radiation- attenuated vaccine in chimpanzees. Infect. Immun., 2001, 69:5352-5362
[8]. Francis P and Bickle Q .Cloning of 21.7-kDa vaccine dominant antigen gene of Schisto.soma mansoni reveals an EF-hand like motif. Mol Biochem Parasitol., 1992, 50:215-224.
[9]. Ganley-Leal, L.M., J. Guarner, C.W. Todd, A.A. Da'dara, G.L. Freeman, Jr., A.E. Boyer, D.A. Harn and Secor, W.E.,. Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines. Parasite Immunol., 2005, 27: 341-9.
[10]. Harlow E and Lane D. Antibodies A. Laboratory manual. Cold Spring Laboratory, Cold Spring Harbor, New York, 1998, 320-360.